Regression of diabetic retinopathy with anti-VEGF treatment: what is learned from a meta-analysis of four pivotal clinical trials

被引：0

作者：

Do, Diana V. ^{[1
]}

Quan Dong Nguyen ^{[1
]}

Day, Bann-Mo ^{[2
]}

Ecoiffier, Tatiana ^{[2
]}

Stoilov, Ivo ^{[2
]}

机构：

[1] Stanford Univ, Sch Med, Byers Eye Inst, Palo Alto, CA 94304 USA

[2] Genentech Inc, San Francisco, CA 94080 USA

来源：

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2019年 / 60卷 / 09期

关键词：

RANIBIZUMAB;

D O I：

暂无

中图分类号：

R77 [眼科学];

学科分类号：

100212 ;

摘要：

1732

引用

页数：3

共 3 条

[1]

[Anonymous], 2015, NEW ENGL J MED, V372, P1193

[2] Randomized Trial Evaluating Ranibizumab Plus Prompt or Deferred Laser or Triamcinolone Plus Prompt Laser for Diabetic Macular Edema [J].

Elman, Michael J. ;

Aiello, Lloyd Paul ;

Beck, Roy W. ;

Bressler, Neil M. ;

Bressler, Susan B. ;

Edwards, Allison R. ;

Ferris, Frederick L., III ;

Friedman, Scott M. ;

Glassman, Adam R. ;

Miller, Kellee M. ;

Scott, Ingrid U. ;

Stockdale, Cynthia R. ;

Sun, Jennifer K. .

OPHTHALMOLOGY, 2010, 117 (06) :1064-U65

[3] Ranibizumab for Diabetic Macular Edema Results from 2 Phase III Randomized Trials: RISE and RIDE [J].

Quan Dong Nguyen ;

Brown, David M. ;

Marcus, Dennis M. ;

Boyer, David S. ;

Patel, Sunil ;

Feiner, Leonard ;

Gibson, Andrea ;

Sy, Judy ;

Rundle, Amy Chen ;

Hopkins, J. Jill ;

Rubio, Roman G. ;

Ehrlich, Jason S. .

OPHTHALMOLOGY, 2012, 119 (04) :789-801

← 1 →